Abingdon Health CEO Chris Yates Discusses London Listing and Growth Strategy | Chris Yates, CEO, Abingdon Health PLC. 00:10:00

Share On Facebook Share On Twitter

Chris Yates, CEO of Abingdon Health PLC, reveals the company’s London listing debut aimed at accelerating growth. Yates emphasizes their commitment to supporting the UK government with their Covid-19 antibody test and outlines recent developments in manufacturing and launching these tests. Beyond Covid-19, Abingdon Health is expanding into animal health, infectious disease, oncology, and environmental testing.

Recent Videos